Back to Trades
Other4
180 Life Sciences Corp.
ATNF
Total Value
$0
Company Information
- Company Name
- 180 Life Sciences Corp.
- Ticker Symbol
- ATNF
- CIK
- 0001690080
Insider Information
- Name
- Van Lent Eric R
- Role
- Chief Accounting Officer
- Location
- PALO ALTO, CA
Officer
Filing Details
- Filing Date
- Jul 14, 2025
- Transaction Date
- Jul 12, 2025
- Accession Number
- 0001213900-25-063840
- Form Type
- 4
Footnotes
- (F1)As originally reported in the Reporting Person's Form 4/A filed with the SEC on June 30, 2025, the options were to vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. On July 12, 2025, the Board of Directors of the Company, with the recommendation of the Compensation Committee of the Board of Directors, approved the accelerated vesting of all the options effective as of such date. The options are subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for the Company's 2025 Option Incentive Plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.